Clinical trial
MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
NCT00252174 · Brigham and Women's Hospital, Other · Terminated
Key facts
| NCT number | NCT00252174 |
|---|---|
| Title | MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer |
| Official title | Phase II Dose-response Pilot Study of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Anxiety Associated With Advanced-stage Cancer. |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Mclean Hospital |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anxiety Disorder, Cancer |
| Intervention type | Behavioral, Drug |
| Interventions | Stage 1 Active Methylenedioxymethamphetamine, Stage 1 Low dose Methylenedioxymethamphetamine, Psychotherapy, Stage 2 Active Methylenedioxymethamphetamine |
| Enrollment | 2 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Nov 11, 2005 |
| Last update posted | Nov 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: